Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
Open accessAbstract
The retinoblastoma protein-interacting zinc finger gene RIZ (PRDM2) is a member, by sequence homology, of a nuclear protein-methyltransferase (MTase) superfamily involved in chromatin-mediated gene expression. The gene produces two protein products, RIZ1 that contains a conserved MTase domain and RIZ2 that lacks the domain. RIZ1 gene expression is frequently silenced in human cancers, and the gene is also a common target of frameshift mutation in microsatellite-unstable cancers. We now report studies of mice with a targeted mutation in the RIZ1 locus. The mutation inactivates RIZ1 but not RIZ2. These RIZ1 mutant mice were viable and fertile but showed a high incidence of diffuse large B-cell lymphomas (DLBL) and a broad spectrum of unusual tumors. RIZ1 deficiency also accelerated tumorigenesis in p53 heterozygous mutant mice. Finally, several missense mutations of RIZ1 were found in human tumor tissues and cell lines; one of these was particularly common in human DLBL tumors. These missense mutations, as well as the previously described frameshift mutation, all mapped to the MTase functional domains. All abolished the capacity of RIZ1 to enhance estrogen receptor activation of transcription. These data suggest a direct link between tumor formation and the MTase domain of RIZ1 and describe for the first time a tumor susceptibility gene among methyltransferases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rb can interact with other histone methyltransferases.
“However, Rb can interact with other histone methyltransferases (Steele-Perkins et al., 2001)”
From Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence (2003) · cites this paper as Steele-Perkins et al., 2001
The paper’s introductory passage identifies RIZ as an Rb-binding protein in the PR/SET methyltransferase family. But the Discussion says direct methyltransferase activity remains to be established for RIZ1, and the paper does not establish that it is a histone methyltransferase. The Rb interaction is supported; the histone-methyltransferase characterization is not. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612 · see citing works
Beighton, P., & Beighton, G. (1997) · Springer eBooks · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,165 · see citing works
Landis, S., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068 · see citing works
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · see citing works
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,334 · see citing works
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · see citing works
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997 · see citing works
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683 · see citing works
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,615 · see citing works
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,214 · see citing works
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
Mowen, K. A., Tang, J., Zhu, W. Z., Schurter, B. T., Shuai, K., Herschman, H. R., & David, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00269-0 · Cited by 484 · see citing works
Venkatachalam, S., Shi, Y., Jones, S. N., Vogel, H. S., Bradley, A., Pinkel, D., & Donehower, L. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449 · see citing works
Transgenesis by means of blastocyst-derived embryonic stem cell lines.
Gossler, A., Doetschman, T., Korn, R., Serfling, E., & Kemler, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9065 · Cited by 426 · see citing works
p53 mutations are associated with histologic transformation of follicular lymphoma
Coco, F. L., Gaïdano, G., Louie, D., Offit, K., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1993) · Blood · doi:10.1182/blood.v82.8.2289.2289 · Cited by 363 · see citing works
Diagnostic Relevance of Clonal Cytogenetic Aberrations in Malignant Soft-Tissue Tumors
Fletcher, J. A., Kozakewich, H. P., Hoffer, F. A., Lage, J. M., Weidner, N., Tepper, R., Pinkus, G. S., Morton, C. C., & Corson, J. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240702 · Cited by 317 · see citing works
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
Coco, F. L., Ye, B., Lista, F., Corradini, P., Offit, K., Knowles, D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1994) · Blood · doi:10.1182/blood.v83.7.1757.bloodjournal8371757 · Cited by 316 · see citing works
Huang, N., Baur, E. V., Garnier, J., Lerouge, T., Vonesch, J., Lutz, Y., Chambon, P., & Losson, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3398 · Cited by 259 · see citing works
Trends in the biochemical pharmacology of 5′-deoxy-5′-methylthioadenosine
Williams-Ashman, H. G., Seidenfeld, J., & Galletti, P. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90171-x · Cited by 253 · see citing works
Fears, S. C., Mathieu, C., Zeleznik‐Le, N. J., Huang, S., Rowley, J. D., & Nucifora, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1642 · Cited by 197 · see citing works
Buyse, I. M., Shao, G. Q., & Huang, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4467 · Cited by 189 · see citing works
Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
Chadwick, R. B., Jiang, G. L., Bennington, G. A., Yuan, B., Johnson, C. K. H., Stevens, M. W., Niemann, T. H., Peltomäki, P., Huang, S., & de la Chapelle, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040579497 · Cited by 174 · see citing works
Huang, S., Shao, G. Q., & Liu, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.15933 · Cited by 167 · see citing works
Studies on the Formation of Transfer Ribonucleic Acid-Ribosome Complexes
Pestka, S. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91792-8 · Cited by 155 · see citing works
Methionine synthesis from 5’-methylthioadenosine in rat liver
Backlund, P. S., & Smith, R. A. (1982) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-06343-7_102 · Cited by 148 · see citing works
Hosokawa, Y., & Arnold, A. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199805)22:1 · Cited by 147 · see citing works
He, L., Yu, J., Liu, L., Buyse, I. M., Wang, M., Yang, Q. C., Nakagawara, A., Brodeur, G. M., Shi, Y. E., & Huang, S. (1998) · PubMed · Cited by 145 · see citing works
Nakata, T., Kitamura, Y., Shimizu, K., Tanaka, S., Fujimori, M., Yokoyama, S., Ito, K., & Emi, M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199906)25:2 · Cited by 133 · see citing works
Methionine synthesis from 5'-methylthioadenosine in rat liver.
Backlund, P. S., & Smith, R. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69835-2 · Cited by 126 · see citing works
(1991) · PubMed · Cited by 123 · see citing works
MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas
Ladanyi, M., Offit, K., Jhanwar, S., Filippa, D. A., & CHAGANTI, R. S. K. (1991) · Blood · doi:10.1182/blood.v77.5.1057.1057 · Cited by 120 · see citing works
Nobori, T., Takabayashi, K., Tran, P. T., Orvis, L., Batova, A., Yu, A. L.-T., & Carson, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6203 · Cited by 113 · see citing works
Schmid, M., Malicki, D. M., Nobori, T., Rosenbach, M., Campbell, K., Carson, D. A., & Carrera, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202205 · Cited by 107 · see citing works
Liu, L., Shao, G. Q., Steele-Perkins, G., & Huang, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2984 · Cited by 98 · see citing works
Piao, Z. H., Fang, W., Malkhosyan, S. R., Kim, H., Horii, A., Perucho, M., & Huang, S. (2000) · PubMed · Cited by 84 · see citing works
The yin-yang of PR-domain family genes in tumorigenesis.
Jiang, G. L., & Huang, S. (2000) · PubMed · doi:10.14670/hh-15.109 · Cited by 76 · see citing works
Lee, M., Liu, Y., & Zhang, X.-K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4194 · Cited by 70 · see citing works
Report of the Second International Workshop on Human Chromosome 1 Mapping 1995
Weith, A., & Vance, J. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134173 · Cited by 69 · see citing works
The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action
Abbondanza, C., Medici, N., Nigro, V., Rossi, V., Gallo, L., Piluso, G., Belsito, A., Roscigno, A., Bontempo, P., Puca, A. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050015697 · Cited by 65 · see citing works
A bird's eye view of global methylation
Eng, C., Herman, J. G., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/72730 · Cited by 62 · see citing works
Jiang, G., & Huang, S. (2001) · PubMed · Cited by 61 · see citing works
Procopio, A. D., Strizzi, L., Vianale, G., Betta, P., Puntoni, R., Fontana, V., Tassi, G., Gareri, F., & Mutti, L. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999 · Cited by 52 · see citing works
Muraosa, Y., Takahashi, K., Yoshizawa, M., & Shibahara, S. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00471.x · Cited by 50 · see citing works
The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action
Abbondanza, C., Medici, N., Nigro, V., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3130 · Cited by 48 · see citing works
Biologic and molecular characterization of non-Hodgkinʼs lymphoma
Gaïdano, G., & Dalla‐Favera, R. (1993) · Current Opinion in Oncology · doi:10.1097/00001622-199309000-00002 · Cited by 44 · see citing works
Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma
Fang, W., Piao, Z. H., Buyse, I. M., Simón, D., Sheu, J., Perucho, M., & Huang, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1667 · Cited by 36 · see citing works
Medici, N., Abbondanza, C., Nigro, V., Rossi, V., Piluso, G., Belsito, A., Gallo, L., Roscigno, A., Bontempo, P., Puca, A. A., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1604 · Cited by 33 · see citing works
A male germ cell tumor-susceptibility-determining locus, pgct1 , identified on murine chromosome 13
Muller, A. J., Teresky, A. K., & Levine, A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140208197 · Cited by 33 · see citing works
Identification and cloning of the G3B cDNA encoding a 3′ segment of a protein binding to GATA-3
Shapiro, V. S., Lee, P., & Winoto, A. (1995) · Gene · doi:10.1016/0378-1119(95)00420-b · Cited by 30 · see citing works
Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma
Rienzo, A. D., Jhanwar, S. C., & Testa, J. R. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200007)28:3 · Cited by 30 · see citing works
Flagged first, then by citations
2 of the 52 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1279 · Cited by 2,350 · see citing works
“Interestingly, the Riz1 gene, which encodes a histone methyltransferase that can associate with Rb, was found by Huang and colleagues to sometimes be inactivated epigenetically and act as a tumour suppressor in mic”
BackgroundRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · see citing works
Writing, erasing and reading histone lysine methylations
Hyun, K., Jeon, J., Park, K., & Kim, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.11 · Cited by 1,250 · see citing works
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · see citing works
Histone methylation in transcriptional control
Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908 · see citing works
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489 · see citing works
“Interestingly, only RIZ1 harbors a SET domain and appears to be the main target of inactivation in tumors (Huang 2002), and mice lacking Riz1 function only are prone to tumor formation (Steele-Perkins et al. 2001).”
BackgroundGarcía-Bassets, I., Kwon, Y., Telese, F., Préfontaine, G. G., Hutt, K. R., Cheng, C. S., Ju, B., Ohgi, K. A., Wang, J., Escoubet‐Lozach, L., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.038 · Cited by 438 · see citing works
Chromatin remodeling and cancer, part I: covalent histone modifications
Wang, G. G., Allis, C. D., & Chi, P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.003 · Cited by 416 · see citing works
“Furthermore, missense mutations that abolish the HMT activity of RIZ1 are found in human cancers [37, 39 ], suggesting a direct causal effect Table 1. Examples of histone methylation and cancer Classes of histone modification Histone-modifying enzymes and binding”
BackgroundHistone lysine methylation and demethylation pathways in cancer
Varier, R. A., & Timmers, H. T. M. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.002 · Cited by 338 · see citing works
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 321 · see citing works
Histone methyltransferases in cancer
Albert, M., & Helin, K. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.10.007 · Cited by 312 · see citing works
“M Diffuse B-cell lymphoma (DBCL) Knockout mice [158]”
BackgroundUnsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287 · see citing works
The prdm family: expanding roles in stem cells and development
Hohenauer, T., & Moore, A. W. (2012) · Development · doi:10.1242/dev.070110 · Cited by 265 · see citing works
“They also include the enzyme Prmt5 (protein methyltransferase 5), which methylates arginines to create a repressive state, and Lsd1 (lysinespecific demethylase 1, Kdm1a), which primarily promotes repression through erasure of activating H3K4 (histone H3 lysine 4) methylation marks.”
BackgroundInfluentialYeung, M. L., Houzet, L., Yedavalli, V. S. R. K., & Jeang, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010033 · Cited by 263 · see citing works
Cancer genetics of epigenetic genes
Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. P., & Caldas, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm021 · Cited by 249 · see citing works
“Targeted inactivating mutations of PRDM2 in mice are associated with development of large B-cell lymphoma and a range of unusual tumors (168).”
BackgroundMutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
Tam, W., Gomez, M. F., Chadburn, A., Lee, J. W., Chan, W. C., & Knowles, D. M. (2006) · Blood · doi:10.1182/blood-2005-09-3778 · Cited by 229 · see citing works
Dynamic protein methylation in chromatin biology
Ng, S. S., Yue, W. W., Oppermann, U. C. T., & Klose, R. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8303-z · Cited by 226 · see citing works
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Saddic, L., West, L. E., Aslanian, A., Yates, J. R., Rubin, S. M., Gozani, O., & Sage, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137612 · Cited by 222 · see citing works
A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance
Khurana, S., Kruhlak, M. J., Kim, J., Tran, A. D., Liu, J., Nyswaner, K., Shi, L., Jailwala, P., Sung, M.-H., Hakim, O., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.024 · Cited by 220 · see citing works
“PRDM2 is a PR/SET domain protein and has been implicated in tumor suppression in mice and humans (Kim et al., 2003; Steele-Perkins et al., 2001).”
BackgroundSelf-citationPRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201 · see citing works
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialLiu, G., Bollig-Fischer, A., Kreike, B., van de Vijver, M., Abrams, J., Ethier, S., & Yang, Z.-Q. (2009) · Oncogene · doi:10.1038/onc.2009.297 · Cited by 208 · see citing works
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and a broad spectrum of unusual tumors (Steele-Perkins et al., 2001).”
BackgroundInfluentialThe control of histone lysine methylation in epigenetic regulation
Völkel, P., & Angrand, P. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.009 · Cited by 196 · see citing works
Iacobuzio–Donahue, C. A. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151442 · Cited by 188 · see citing works
Inactivation of a histone methyltransferase by mutations in human cancers.
Kim, K., Geng, L., & Huang, S. (2003) · PubMed · Cited by 183 · see citing works
Du, Y., Carling, T., Fang, W., Piao, Z. H., Sheu, J., & Huang, S. (2001) · PubMed · Cited by 170 · see citing works
Epigenetic regulation of normal and malignant hematopoiesis
Rice, K. L., Hormaeche, I., & Licht, J. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210755 · Cited by 158 · see citing works
“RIZ1 knockout mice develop B-cell lymphoma (Steele-Perkins et al., 2001), and in chronic myelogenous leukemia (CML), blastic transformation is associated with loss of heterozygosity in the vicinity of RIZ1 and a decrease in RIZ1 expression (Pastural et al., 2007).”
BackgroundHistone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes
Gibbons, R. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi106 · Cited by 153 · see citing works
“Furthermore, gene knockout mice that lack RIZ1 are prone to develop B cell lymphomas (30).”
BackgroundHistone methyltransferases, diet nutrients and tumour suppressors
Huang, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc819 · Cited by 150 · see citing works
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 147 · see citing works
“Although spontaneous alterations in UV39H1 have not been documented in human tumors, another Rb-binding HMT, RIZ1, is frequently silenced or mutated in uman cancers, and targeted mutation of RIZ1 in mice results in ymphomagenesis [36].”
BackgroundNishikata, I., Sasaki, H., Iga, M., Tateno, Y., Imayoshi, S., Asou, N., Nakamura, T., & Morishita, K. (2003) · Blood · doi:10.1182/blood-2002-12-3944 · Cited by 145 · see citing works
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 144 · see citing works
BLIMP1 guides the fate of effector B and T cells
Nutt, S. L., Fairfax, K. A., & Kallies, A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2204 · Cited by 139 · see citing works
Fumasoni, I., Meani, N., Rambaldi, D., Scafetta, G., Alcalay, M., & Ciccarelli, F. D. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-187 · Cited by 136 · see citing works
“All these genes can code for both a full-length protein and an isoform without the PR-domain, which is often overexpressed in cancer [22,23].”
Nanjundan, M., Nakayama, Y., Cheng, K. W., Lahad, J. P., Liu, J., Lu, K., Kuo, W.-L., Smith‐McCune, K., Fishman, D. A., Gray, J. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2366 · Cited by 133 · see citing works
“EVI1, which has the potential to act as a protein methyltransferase (32).”
BackgroundGyőry, I., Fejér, G., Ghosh, N., Seto, E., & Wright, K. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3125 · Cited by 130 · see citing works
“The recent development of mice with normal expression of RIZ2, but a selective disruption of the RIZ1 isoform, confirms a role in tumor development (20).”
BackgroundRobertson, E. J., Charatsi, I., Joyner, C. J., Koonce, C. H., Morgan, M., Islam, A., Paterson, C. A., Lejsek, E., Arnold, S. J., Kallies, A., et al. (2007) · Development · doi:10.1242/dev.012047 · Cited by 129 · see citing works
Greenwood, E. (2001) · Nature reviews. Cancer · doi:10.1038/35094036 · Cited by 120 · see citing works
Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis
Pogribny, I. P., Tryndyak, V., Muskhelishvili, L., Rusyn, I., & Ross, S. A. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.216s · Cited by 116 · see citing works
An expanding job description for Blimp-1/PRDM1
Bikoff, E. K., Morgan, M. A., & Robertson, E. J. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.05.005 · Cited by 108 · see citing works
Epigenetic regulation of development by histone lysine methylation
Dambacher, S., Hahn, M., & Schotta, G. (2010) · Heredity · doi:10.1038/hdy.2010.49 · Cited by 108 · see citing works
“(2003) Viable Tumorigenesis (Steele-Perkins et al., 2001) Prdm3 E13.”
PRDM5 is silenced in human cancers and has growth suppressive activities
Deng, Q., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207615 · Cited by 102 · see citing works
“Deficiency in the PR-domain of PRDM2 causes tumor susceptibility in mice and mutations in this domain are present in human cancers (Steele-Perkins et al., 2001; Kim et al., 2003).”
BackgroundThe role of PRDMs in cancer: one family, two sides
Mzoughi, S., Tan, Y. X., Low, D. H. P., & Guccione, E. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.009 · Cited by 103 · see citing works
Histone Modifications in Cancer Biology and Prognosis
Kurdistani, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_5 · Cited by 102 · see citing works
Yoshida, M., Nosaka, K., Yasunaga, J., Nishikata, I., Morishita, K., & Matsuoka, M. (2003) · Blood · doi:10.1182/blood-2003-07-2482 · Cited by 101 · see citing works
Hickabottom, M., Parker, G. A., Freemont, P. S., Crook, T., & Allday, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208116200 · Cited by 92 · see citing works
PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation
Zazzo, E. D., Rosa, C. D., Abbondanza, C., & Moncharmont, B. (2013) · Biology · doi:10.3390/biology2010107 · Cited by 91 · see citing works
“This would explain why the PRDM2 (PR-minus) form is unable to produce enhancer effects in presence of estradiol, as observed with ERE-Luc reporter assay experiments in vitro [39], despite the presence of domains for the recruitment of p300 and p160 co-activators [34].”
BackgroundTIP30 deficiency increases susceptibility to tumorigenesis.
Ito, M., Jiang, C. Y., Krumm, K., Zhang, X., Pecha, J., Zhao, J., Guo, Y., Roeder, R. G., & Xiao, H. (2003) · PubMed · Cited by 90 · see citing works
Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors
Costa‐Guda, J., & Arnold, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.005 · Cited by 89 · see citing works
“However, aberrant expression of RIZ1 has not been reported in parathyroid tumors and loss of RIZ1 does not appear to be able to drive parathyroid tumor development in genetically engineered mice (Steele-Perkins et al., 2001).”
Regulation of transcription and chromatin structure by pRB: Here, there and everywhere
Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 88 · see citing works
Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79 · see citing works
Mutations and epimutations in the origin of cancer
Peltomäki, P. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.12.001 · Cited by 83 · see citing works
Yang, Z., Jones, A., Widschwendter, M., & Teschendorff, A. E. (2015) · Genome biology · doi:10.1186/s13059-015-0699-9 · Cited by 83 · see citing works
“In agreement with previous studies, PRDM2 has been found to be widely underexpressed in epithelial [68] and hematological cancers [69].”
ResultThe genetic pathogenesis of colorectal cancer
Lynch, J. P., & Hoops, T. C. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00029-1 · Cited by 78 · see citing works
Keynote review: Chromatin control and cancer-drug discovery: realizing the promise
Inche, A. G., & Thangue, N. B. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03691-3 · Cited by 76 · see citing works
Multifaceted Role of PRDM Proteins in Human Cancer
Casamassimi, A., Rienzo, M., Zazzo, E. D., Sorrentino, A., Fiore, D., Proto, M., Moncharmont, B., Gazzerro, P., Bifulco, M., & Abbondanza, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072648 · Cited by 73 · see citing works
“Indeed, an accelerated tumorigenesis was associated with Riz1 deficiency (Riz1-/-) on the p53+/- background [55].”
BackgroundA Histone Methyltransferase Is Required for Maximal Response to Female Sex Hormones
Carling, T., Kim, K., Yang, X. H., Gu, J., Zhang, X.-K., & Huang, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7032-7042.2004 · Cited by 72 · see citing works
“vectors and RIZ1 mutant vectors have been described (42).”
BackgroundMethodInfluentialChittka, A., Arévalo, J. C., Rodriguez-Guzman, M., Pérez, P., Chao, M. V., & Sendtner, M. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200301106 · Cited by 71 · see citing works
“Thus, transcriptional activities of repressive and activating nature have been described for RIZ (Xie et al., 1997; Abbondanza et al., 2000; Steele-Perkins et al., 2001), Blimp-1/PRDI-BF1 (Lin et al., 1997; Ren et al., 1999; Yu et al., 2000), and Evi-1 (Kurokawa et al., 1998; Izutsu et al., 2001; Palmer et al., 2001).”
BackgroundInfluentialHistone Modification Therapy of Cancer
Biancotto, C., Frigè, G., & Minucci, S. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60013-7 · Cited by 69 · see citing works
MacDonald, J. I., & Dick, F. A. (2012) · Genes & Cancer · doi:10.1177/1947601912473305 · Cited by 69 · see citing works
The duality of PRDM proteins: epigenetic and structural perspectives
Tullio, F. D., Schwarz, M. C., Zorgati, H., Mzoughi, S., & Guccione, E. (2021) · FEBS Journal · doi:10.1111/febs.15844 · Cited by 66 · see citing works
Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma
Oshimo, Y., Oue, N., Mitani, Y., Nakayama, H., Kitadai, Y., Yoshida, K., Chayama, K., & Yasui, W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20090 · Cited by 66 · see citing works
Targeting the epigenome for treatment of cancer
Geutjes, E.-J., Bajpe, P. K., & Bernards, R. (2011) · Oncogene · doi:10.1038/onc.2011.552 · Cited by 61 · see citing works
“KMT8 can be silenced by promoter hyper-methylation; is located on the frequently deleted 1p36 chromosomal locus; and is subject to PR domain-targeting loss-offunction mutations (He et al., 1998; Chadwick et al., 2000; Steele-Perkins et al., 2001).”
BackgroundInfluentialCheedipudi, S. M., Puri, D., Saleh, A., Gala, H., Rumman, M., Pillai, M. S., Sreenivas, P., Arora, R., Sellathurai, J., Schrøder, H. D., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv567 · Cited by 59 · see citing works
“Of the PRDM2 isoforms, RIZ1 (an H3K9 methyl transferase, (38,39) is deleted in cancers, but RIZ2, which lacks the PR domain, is not; targeted deletion of just RIZ1 increased tumor incidence (40).”
BackgroundPastural, É., Takahashi, N., Dong, W.-F., Bainbridge, M. N., Hull, A. R., Pearson, D., Huang, S., Lowsky, R., DeCoteau, J. F., & Geyer, C. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209959 · Cited by 58 · see citing works
“RIZ1 / mice have a high incidence of diffuse large B-cell lymphoma and a broad spectrum of unusual tumors (Steele-Perkins et al., 2001).”
BackgroundBiallelic inactivation of the RIZ1 gene in human gastric cancer
Tokumaru, Y., Nomoto, S., Jerónimo, C., Henrique, R., Harden, S., Trink, B., & Sidransky, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206403 · Cited by 58 · see citing works
Carling, T., Du, Y., Fang, W., Correa, P., & Huang, S. (2003) · Surgery · doi:10.1016/s0039-6060(03)00422-7 · Cited by 57 · see citing works
Chapter 4 Histone Demethylases and Cancer
Kampranis, S. C., & Tsichlis, P. N. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02004-1 · Cited by 56 · see citing works
“…Huang (2004), Du et al. (2005), Hasegawa et al. (2007), Kim et al. (2003), Lakshmikuttyamma et al. (2008), Lal et al. (2006), Piao et al. (2008), Steele-Perkins et al. (2001), Yoon et al. (2007) EZH2/KMT6 Overexpressed in a variety of human tumors, including aggressive prostate and breast…”
BackgroundThe Role of Histone Modifications and Variants in Regulating Gene Expression in Breast Cancer
Dalvai, M., & Bystricky, K. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9167-z · Cited by 55 · see citing works
Reclassification of oligoastrocytomas by loss of heterozygosity studies
Eoli, M., Bissola, L., Bruzzone, M. G., Pollo, B., Maccagnano, C., Simone, T. D., Valletta, L., Silvani, A., Bianchessi, D., Broggi, G., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21759 · Cited by 55 · see citing works
“ferase superfamily involved in chromatin-mediated gene expression.(24) RIZ1 mutations were not detected in 40 oligodendrogliomas,(25) but investigations on its expression, that in other tumors can be decreased by promoter methylation or haplotype insufficiency,(26) should be performed before ruling out its involvement…”
BackgroundCharacterization of the PR domain of RIZ1 histone methyltransferase
Derunes, C., Briknarová, K., Geng, L., Li, S., Gessner, C. R., Hewitt, K. M., Wu, S., Huang, S., Woods, V. I., & Ely, K. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.190 · Cited by 54 · see citing works
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53 · see citing works
RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma
Lal, G., Padmanabha, L., Smith, B. J., Nicholson, R. M., Howe, J. R., O'Dorisio, M. S., & Domann, F. E. (2006) · Cancer · doi:10.1002/cncr.22325 · Cited by 52 · see citing works
“In tumors characterized by chromosomal instability, inactivation of RIZ1 is related to allelic loss and epigenetic silencing involving promoter hypermethylation, whereas mutations are rare.(9,11,16) Promoter hypermethylation has been shown to be associated with reduced RIZ1 expression in solid tumors, such as gastric(…”
BackgroundPRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis
Mzoughi, S., Fong, J. Y., Papadopoli, D. J., Koh, C. M., Hulea, L., Pigini, P., Tullio, F. D., Andreacchio, G., Hoppe, M. M., Wollmann, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17064-0 · Cited by 51 · see citing works
Chang, H. W., Chan, A., Kwong, D. L. �., Wei, W., Sham, J. S. T., & Yuen, A. P. W. (2003) · PubMed · Cited by 49 · see citing works
The Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis
Dannenberg, J.-H., & te Riele, H. P. J. (2006) · Results and Problems in Cell Differentiation · doi:10.1007/400_002 · Cited by 47 · see citing works
Methylation profiling in multiple myeloma
Chim, C. S., Kwong, Y., Fung, T. K., & Liang, R. H. S. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.08.008 · Cited by 47 · see citing works
“acid receptor beta (RARβ), retinoblastoma protein-binding zinc finger protein (RIZ1), and von Hippel-Lindau (VHL)), [2,4,7,8,10,11] apoptosis (death-associated protein kinase (DAPK)), [12,13] and cell adhesion (E-cadherin (E-CAD)) [14].”
BackgroundAltered expression of retinoblastoma protein‐interacting zinc finger gene, RIZ, in human leukaemia
Sasaki, O., Meguro, K., Tohmiya, Y., Funato, T., Shibahara, S., & Sasaki, T. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03972.x · Cited by 46 · see citing works
“…et al, 1998; Jiang et al, 1999; Chadwick et al, 2000; Gazzerro et al, 2001), and the RIZ1 gene knock-out studies in mice, demonstrating a high incidence of a broad spectrum of tumours including diffuse large B-cell lymphomas (Steele-Perkins et al, 2001), suggest tumour suppressor activity by RIZ1.”
BackgroundInfluentialLinking Covalent Histone Modifications to Epigenetics: The Rigidity and Plasticity of the MarksPreprint
Wang, Y., Wysocka, J., Perlin, J. R., Leonelli, L., Allis, C. D., & Coonrod, S. A. (2004) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2004.69.161 · Cited by 42 · see citing works
Epigenetik – ein Epizentrum der Genregulation: Histone und histonmodifizierende Enzyme
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie · doi:10.1002/ange.200461346 · Cited by 41 · see citing works
Leukemogenesis of the EVI1/MEL1 Gene Family
Morishita, K. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06174 · Cited by 41 · see citing works
“The PR domain of the PRDM gene family is a subclass of the SET domain, which is most closely related to the known histone methyltransferases [ 32 ].”
BackgroundGazzerro, P., Abbondanza, C., D'Arcangelo, A., Rossi, M., Medici, N., Moncharmont, B., & Puca, G. A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.002 · Cited by 39 · see citing works
Liu, Z. Y., Wang, J. Y., Liu, H. H., Ma, X.-M., Wang, C. L., Zhang, X. P., Tao, Y. Q., Lu, Y. C., Liao, J., & Hu, G. (2012) · Oncogene · doi:10.1038/onc.2012.155 · Cited by 38 · see citing works
Epigenetic alterations in human parathyroid tumors
Verdelli, C., Forno, I., Vaira, V., & Corbetta, S. (2015) · Endocrine · doi:10.1007/s12020-015-0555-4 · Cited by 37 · see citing works
“However, aberrant expression of RIZ1 protein was not detected in parathyroid tumors and loss of RIZ1 does not appear to be able to drive parathyroid tumor development in genetically engineered mice [11] (Table 1).”
BackgroundLei, Q., Liu, X., Fu, H., Sun, Y., Wang, L., Xu, G., Wang, W., Yu, Z., Liu, C., Li, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6652 · Cited by 37 · see citing works
“Overexpression of PRDM2 induces cell apoptosis and differentiation, possibly via H3K9 histone methylation, in CML blast crisis cell lines [7, 8].”
BackgroundChang, Y., Chang, C., Huang, H., Lin, C., Yeh, K., & Chang, J. (2018) · Endocrine Pathology · doi:10.1007/s12022-018-9543-6 · Cited by 37 · see citing works
Is There a Histone Code for Cellular Quiescence?
Bonitto, K., Sarathy, K., Atai, K., Mitra, M., & Coller, H. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739780 · Cited by 36 · see citing works
“In mammals, there are multiple methyltransferases that add methyl groups to histone H3 lysine 9 including the 17 members of the PRDM family of proteins (Steele-Perkins et al., 2001; Hyun et al., 2017).”
BackgroundReid, A. G., & Nacheva, E. P. (2003) · Leukemia · doi:10.1038/sj.leu.2403162 · Cited by 36 · see citing works
Histone Methyltransferases in Tumor Suppression
Kim, K., & Huang, S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.629 · Cited by 36 · see citing works
“Silencing/mutation, G2/M arrest (43), NM_012231 proapoptoic, binds Rb, yin-yang”
Congdon, L. M., Sims, J. K., Tuzon, C. T., & Rice, J. C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1377 · Cited by 35 · see citing works
“Riz1 was originally identified as an Rb-binding protein that functions as a tumor suppressor by inducing cell cycle arrest and apoptosis (18,20).”
BackgroundGenetic background influences susceptibility to chemotherapy-induced hematotoxicity
Gatti, D. M., Weber, S. N., Goodwin, N. C., Lammert, F., & Churchill, G. A. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.23 · Cited by 32 · see citing works
Molecular Basis of Primary Hyperparathyroidism
Arnold, A., & Levine, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00018-7 · Cited by 35 · see citing works
Human PRDM2: Structure, function and pathophysiology
Sorrentino, A., Rienzo, M., Ciccodicola, A., Casamassimi, A., & Abbondanza, C. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.06.002 · Cited by 34 · see citing works
Chromatin‐modifying proteins in cancer
Fog, C. K., Jensen, K. T., & Lund, A. H. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_776.xml.x · Cited by 35 · see citing works
Kolomietz, E., Marrano, P. M., Yee, K. W. L., Thai, B., Braude, I., Kolomietz, A., Chun, K., Minkin, S., Kamel‐Reid, S., Minden, M. D., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402969 · Cited by 34 · see citing works
Context-specific regulation of cancer epigenomes by histone and transcription factor methylation
Sarris, M. E., Nikolaou, K., & Talianidis, I. (2013) · Oncogene · doi:10.1038/onc.2013.87 · Cited by 32 · see citing works
RIZ1: a potential tumor suppressor in glioma
Zhang, C., Zhu, Q., He, H., Jiang, L., Qiang, Q., Hu, L., Hu, G., Jiang, Y., Ding, X., & Lu, Y. (2015) · BMC Cancer · doi:10.1186/s12885-015-2023-1 · Cited by 31 · see citing works
Dong, S., Zhang, H., Wang, B., Sun, P., Wang, Y.-G., & Zhang, P. (2014) · Oncology Reports · doi:10.3892/or.2014.3307 · Cited by 30 · see citing works
Piao, G., Piao, W., He, Y., Zhang, H. H., Wang, G. Q., & Piao, Z. H. (2008) · PubMed · doi:10.14670/hh-23.1171 · Cited by 29 · see citing works
DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer
Hasegawa, Y., Matsubara, A., Teishima, J., Seki, M., Mita, K., Usui, T., Oue, N., & Yasui, W. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00338.x · Cited by 29 · see citing works
Haney, S. L., Hlady, R. A., Opavska, J., Klinkebiel, D. L., Pirruccello, S. J., Dutta, S., Datta, K., Simpson, M. A., Wu, L., & Opavský, R. (2015) · Oncogene · doi:10.1038/onc.2014.472 · Cited by 28 · see citing works
- Authors
- Steele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., Chadwick, R. B., de la Chapelle, A., Zhang, X.-K., Speleman, F., & Huang, S.
- Affiliations
- Cleveland Clinic (US)
- Tufts University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-09-01
- Volume
- 15
- Issue
- 17
- Pages
- 2250-2262
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC312773
- OpenAlex
- W2166083262
- Cited by
- 208
- References
- 52
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 12 · 2016: 8 · 2015: 15 · 2014: 8 · 2013: 9 · 2012: 10
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Tobacco-Related Disease Research Program
- National Institutes of Health (5r01ca076146-03)
- National Cancer Institute (CA-76146, CA60988, R01CA060988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- RIZ1, PRDM2, cancer susceptibility genes, diffuse large B-cell lymphoma, carcinogenesis, microsatellite instability, frameshift mutation, missense mutations
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Base Sequence, DNA Mutational Analysis, DNA-Binding Proteins, Multigene Family, Heterozygote, Humans, Immunoglobulin Heavy Chains, Karyotyping, Models, Genetic, Molecular Sequence Data, Mutation, Neoplasms, Nuclear Proteins, Protein Binding, Histone-Lysine N-Methyltransferase, Receptors, Estrogen, Time Factors, Transcription Factors, Tumor Cells, Cultured, Blotting, Southern, Blotting, Northern, Transcriptional Activation, Genes, p53, Retinoblastoma Protein, Mutagenesis, Site-Directed, Frameshift Mutation, Protein Structure, Tertiary, Microsatellite Repeats, Genetic Predisposition to Disease, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review